News & Analysis as of

Regulatory Requirements › Legislative Agendas › Manufacturers

Bradley Arant Boult Cummings LLP

Cloud Control: Alabama’s Newest Nicotine Regulation That’s Just Too “Juicy” to Ignore

Bradley Arant Boult Cummings LLP on

On May 14, Alabama Gov. Kay Ivey signed Alabama HB8 into law. Effective June 1, HB8 introduced sweeping changes that will reshape how nicotine products are sold, marketed, and regulated in Alabama. You heard that right,...more

Bradley Arant Boult Cummings LLP

And Now the Rest of the Story: Alabama’s New Hemp Restrictions Also Legitimize Segments of the Industry

Bradley Arant Boult Cummings LLP on

They paved paradise and put up a parking lot. That’s been the tenor of what I’ve heard and read from stakeholders in the Alabama hemp industry in response to the enactment of comprehensive hemp reform legislation earlier this...more

Bass, Berry & Sims PLC

Tennessee Enacts Sweeping Changes to Regulation of Hemp-Derived Cannabinoid Products

Bass, Berry & Sims PLC on

At the conclusion of the 114th General Assembly, Tennessee legislators passed SB1413/HB1376, a lengthy bill overhauling the regulation of Hemp-Derived Cannabinoid Products (HDCPs). The bill was controversial and while some...more

IR Global

From Disaster to Reform: The Ongoing Legal Legacy of Grenfell Tower

IR Global on

In the wake of the Grenfell Tower tragedy in 2017, which claimed 72 lives, the UK government has undertaken significant measures to address the systemic failures that contributed to the disaster. This year, several key...more

Spilman Thomas & Battle, PLLC

Decoded - Technology Law Insights, V 5, Issue 10, December 2024

Spilman Thomas & Battle, PLLC on

Happy Holidays and welcome to our year-end issue of Decoded. We hope you enjoyed reading our technology law insights e-newsletter this year. We are already planning for 2025. ...more

Sheppard Mullin Richter & Hampton LLP

FDA’s Proposed Rule on LDT Regulation and the Debate over Agency Deference

Sheppard Mullin Richter & Hampton LLP on

Earlier this month, the Food and Drug Administration (“FDA” or “the Agency”) issued a highly anticipated proposed rule outlining the regulatory framework and implementation plan for Laboratory Developed Tests (“LDTs”). The...more

McDermott Will & Schulte

Special Report - 2022 FDA Year in Review

McDermott Will & Schulte on

As the United States’ primary public health and consumer protection agency, the US Food and Drug Administration (FDA) regulates at least one quarter of the nation’s economy and exerts significant influence over global...more

Jenner & Block

Client Alert: PFAS in Consumer Products: Developing a Proactive and Strategic Game Plan

Jenner & Block on

Per- and polyfluoroalkyl substances (PFAS) in consumer products continue to be in the regulatory and litigation spotlight in 2023. Manufacturers and downstream businesses should be actively preparing to comply with the...more

Farrell Fritz, P.C.

Legislation Affecting the Pharmaceutical Industry

Farrell Fritz, P.C. on

During a year in which legislative activity was restrained by a variety of factors, most notably the Senate’s inability to maintain a consistent majority, the New York State Legislature nonetheless still passed 641 bills,...more

9 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide